The Perspective of Exosomal MicroRNAs as Biomarkers for Preclinical Alzheimer's Disease
Biol Psychiatry
.
2022 Jul 1;92(1):5-7.
doi: 10.1016/j.biopsych.2022.04.006.
Author
Urszula Wojda
1
Affiliation
1
Laboratory of Preclinical Testing of Higher Standard, Nencki Institute of Experimental Biology of Polish Academy of Sciences, Warsaw, Poland. Electronic address: u.wojda@nencki.gov.pl.
PMID:
35710161
DOI:
10.1016/j.biopsych.2022.04.006
No abstract available
Publication types
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Alzheimer Disease* / diagnosis
Alzheimer Disease* / genetics
Biomarkers
Exosomes* / genetics
Humans
MicroRNAs* / genetics
Substances
Biomarkers
MicroRNAs